RT Book, Section
A1 Thurston, Maria Miller
A1 Lin, Jenny
A2 Chisholm-Burns, Marie A.
A2 Schwinghammer, Terry L.
A2 Malone, Patrick M.
A2 Kolesar, Jill M.
A2 Bookstaver, P. Brandon
A2 Lee, Kelly C.
SR Print(0)
ID 1187024804
T1 Gout and Hyperuricemia
T2 Pharmacotherapy Principles & Practice, 6e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260460278
LK ppp.mhmedical.com/content.aspx?aid=1187024804
RD 2024/10/06
AB LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Explain  the  pathophysiologic  mechanisms  underlying  gout  and  hyperuricemia.Recognize  major  risk  factors  for  developing  gout  in  a  given  person.Assess  the  signs  and  symptoms  of  an  acute  gout  attack.List  the  treatment  goals  for  a  patient  with  gout.Develop  a  pharmacotherapeutic  plan  for  a  patient  with  acute  gouty  arthritis  that  includes  individualized  drug  selection  and  monitoring  for  efficacy  and  safety.Identify  patients  for  whom  prophylactic  urate-lowering  therapy  for  gout  and  hyperuricemia  is  warranted.Formulate  appropriate  educational  information  for  a  patient  on  lifestyle  modifications  to  help  prevent  gouty  arthritis  attacks.Select  an  appropriate  drug  to  reduce  serum  uric  acid  (SUA)  levels  in  patients  with  gout,  and  outline  a  plan  for  monitoring  efficacy  and  toxicity.